Pre-existing antidepressants and the outcome of group cognitive behaviour therapy for social phobia

被引:14
作者
Rosser, S [1 ]
Erskine, A [1 ]
Crino, R [1 ]
机构
[1] Univ New S Wales, St Vincents Hosp, Clin Res Unit Anxiety Disorders, Sydney, NSW, Australia
关键词
antidepressant medication; cognitive behaviour therapy; social phobia; treatment outcome;
D O I
10.1080/j.1440-1614.2004.01345.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: This is a naturalistic treatment outcome study investigating the impact of pre-existing antidepressant use on the effectiveness of group cognitive behaviour therapy (CBT) for social phobia. Method: Of the 133 participants who completed the CBT program, 49 reported taking antidepressants (CBT + AD group), while 84 reported not taking antidepressants (CBT group). The treatment program involves 40 h of structured, group-based CBT over 7 weeks. The dependent measures included the Social Phobia Scale and Social Interaction Anxiety Scale, the Fear of Negative Evaluation Scale, the Depression, Anxiety and Stress Scale and the Short Form-12. Results: Both the CBT + AD group and the CBT group improved significantly across treatment on all dependent measures. There were no significant differences between the groups on any outcome measure and the rate of improvement from pre- to post-treatment for both groups did not differ. Conclusions: Pre-existing antidepressants did not significantly enhance or detract from the positive treatment outcome of a structured, group-based CBT program for social phobia.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 53 条
[1]  
Andrews G, 1994, TREATMENT ANXIETY DI
[2]   Paroxetine in social phobia/social anxiety disorder -: Randomised, double-blind, placebo-controlled study [J].
Baldwin, D ;
Bobes, J ;
Stein, DJ ;
Scharwächter, I ;
Faure, M .
BRITISH JOURNAL OF PSYCHIATRY, 1999, 175 :120-126
[3]   Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment [J].
Brunello, N ;
den Boer, JA ;
Judd, LL ;
Kasper, S ;
Kelsey, JE ;
Lader, M ;
Lecrubier, Y ;
Lepine, JP ;
Lydiard, RB ;
Mendlewicz, J ;
Montgomery, SA ;
Racagni, G ;
Stein, MB ;
Wittchen, HU .
JOURNAL OF AFFECTIVE DISORDERS, 2000, 60 (01) :61-74
[4]  
CLARK DB, 1991, AM J PSYCHIAT, V148, P598
[5]   A POWER PRIMER [J].
COHEN, J .
PSYCHOLOGICAL BULLETIN, 1992, 112 (01) :155-159
[6]   A comparison of social phobia outcome measures in cognitive-behavioral group therapy [J].
Cox, BJ ;
Ross, L ;
Swinson, RP ;
Direnfeld, DM .
BEHAVIOR MODIFICATION, 1998, 22 (03) :285-297
[7]  
Davidson JRT, 1998, J CLIN PSYCHIAT, V59, P47
[8]  
Eysenck H., 1975, Manual of the eysenck personality questionnaire
[9]   THE TREATMENT OF SOCIAL PHOBIA - REAL-LIFE REHEARSAL WITH NON-PROFESSIONAL THERAPISTS [J].
FALLOON, IRH ;
LLOYD, GG ;
HARPIN, RE .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1981, 169 (03) :180-184
[10]   Psychological and pharmacological treatments of social phobia: A meta-analysis [J].
Fedoroff, IC ;
Taylor, S .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (03) :311-324